Northern Africa and Western Asia vs Russia: Proportion of the target population who received a 3rd dose of
Northern Africa and Western Asia
50.0%
in 2024
Russia
94.0%
in 2024
Northern Africa and Western Asia rank
33rd
Russia rank
36th
Proportion of the target population who received a 3rd dose of over time
- Northern Africa and Western Asia
- Russia
How they compare
Russia currently reports 94.0% against 50.0% in Northern Africa and Western Asia, a difference of 44.0%.
That makes Russia's figure about 1.9 times Northern Africa and Western Asia's.
The two have swapped places 1 time across 9 shared years of data; in 2016 it was Northern Africa and Western Asia ahead.
Northern Africa and Western Asia ranks 33rd and Russia ranks 36th of 37 groups.
Russia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Northern Africa and Western Asia | Russia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 56.5% | 67.8% | 11.2% | Russia |
| 2020s | 50.6% | 91.0% | 40.4% | Russia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, Northern Africa and Western Asia or Russia?
- Russia, at 94.0% against 50.0% in Northern Africa and Western Asia as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between Northern Africa and Western Asia and Russia?
- 44.0%, with Russia ahead.
- How many years of comparable data are there for Northern Africa and Western Asia and Russia?
- 9 years are reported by both, from 2016 to 2024.
- How do Northern Africa and Western Asia and Russia rank globally for proportion of the target population who received a 3rd dose of?
- Northern Africa and Western Asia ranks 33rd and Russia ranks 36th of 37 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.